Matches in Wikidata for { <http://www.wikidata.org/entity/Q66037671> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q66037671 description "assaig clínic" @default.
- Q66037671 description "clinical trial" @default.
- Q66037671 description "clinical trial" @default.
- Q66037671 description "clinical trial" @default.
- Q66037671 description "clinical trial" @default.
- Q66037671 description "ensaio clínico" @default.
- Q66037671 description "ensayo clínico" @default.
- Q66037671 description "ensayu clínicu" @default.
- Q66037671 description "essai clinique" @default.
- Q66037671 description "klinisch onderzoek" @default.
- Q66037671 description "клінічне випробування" @default.
- Q66037671 name "Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia" @default.
- Q66037671 name "Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia" @default.
- Q66037671 type Item @default.
- Q66037671 label "Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia" @default.
- Q66037671 label "Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia" @default.
- Q66037671 prefLabel "Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia" @default.
- Q66037671 prefLabel "Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia" @default.
- Q66037671 P1050 Q66037671-76F47BBE-90B5-4CE0-A49A-E59454C16701 @default.
- Q66037671 P1132 Q66037671-1EB7AA59-E1BF-4203-95B9-A746E8FB494A @default.
- Q66037671 P1476 Q66037671-CC88A7F6-B235-4F5F-82A3-2A85AAE358D8 @default.
- Q66037671 P17 Q66037671-27ED253A-5DC8-4FB4-9D14-DAF578DD4EA8 @default.
- Q66037671 P3098 Q66037671-8C576ED6-D577-44E9-A037-45E51FEFFD53 @default.
- Q66037671 P31 Q66037671-07836E4F-2C63-4C1B-9C9C-CF6D6DB00717 @default.
- Q66037671 P4135 Q66037671-0C8FE174-5911-48B4-80CF-203ED7C05E9C @default.
- Q66037671 P4844 Q66037671-1745E30A-9FFC-43ED-93DF-291DF8B69093 @default.
- Q66037671 P4844 Q66037671-4469A34E-6F10-4928-979C-BC98FFE2BA42 @default.
- Q66037671 P4844 Q66037671-80604F7F-5D60-4158-9A5F-0A6B5D6C8BEE @default.
- Q66037671 P4844 Q66037671-89FD2D49-93E6-4631-8428-D6E20F3FEF38 @default.
- Q66037671 P4844 Q66037671-BD90433E-3E7F-4BCC-8A1D-2567FB019696 @default.
- Q66037671 P4844 Q66037671-BFE609F7-B8D7-492F-941F-60A8DB3AB66D @default.
- Q66037671 P4844 Q66037671-F87871AC-42A2-4CB4-B47B-DF60FCC12A53 @default.
- Q66037671 P580 Q66037671-B54803FD-925B-48BD-B6E2-2335351A3386 @default.
- Q66037671 P582 Q66037671-02BA2F7B-BED1-46FC-BC6E-24B946A10746 @default.
- Q66037671 P6153 Q66037671-5FBCA5D7-62BC-4C9D-9E17-334700D45824 @default.
- Q66037671 P8363 Q66037671-76BE4D45-9126-45F8-B6D9-551F1192338C @default.
- Q66037671 P1050 Q29496 @default.
- Q66037671 P1132 "+126" @default.
- Q66037671 P1476 "Intensive Induction Therapy for Children With Acute Lymphoblastic Leukemia (ALL) Who Experience a Bone Marrow Relapse" @default.
- Q66037671 P17 Q30 @default.
- Q66037671 P3098 "NCT00049569" @default.
- Q66037671 P31 Q30612 @default.
- Q66037671 P4135 "+21" @default.
- Q66037671 P4844 Q180983 @default.
- Q66037671 P4844 Q18936 @default.
- Q66037671 P4844 Q29004943 @default.
- Q66037671 P4844 Q408524 @default.
- Q66037671 P4844 Q421534 @default.
- Q66037671 P4844 Q424972 @default.
- Q66037671 P4844 Q7160547 @default.
- Q66037671 P580 "2003-01-01T00:00:00Z" @default.
- Q66037671 P582 "2006-03-01T00:00:00Z" @default.
- Q66037671 P6153 Q50497521 @default.
- Q66037671 P8363 Q78089383 @default.